The largest database of trusted experimental protocols

Hela digest

Manufactured by Thermo Fisher Scientific

The HeLa digest is a laboratory product derived from the HeLa cell line, a widely used human cell line in biomedical research. The product provides a standardized and consistent source of cellular material for use in various applications, such as cell culture studies and biochemical analyses. The core function of the HeLa digest is to serve as a reliable and reproducible reference material for research purposes.

Automatically generated - may contain errors

4 protocols using hela digest

1

Standard Peptide Acquisition and Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 6

Standard peptides TAGTSFMMTPYVVTR (SEQ ID NO: 1) and GAILTTMLATR (SEQ ID NO: 2) were purchased from JPT (Berlin, Germany). iRT peptides were from Biognosys (Zurich, Switzerland). MrsA, apomyoglobin and HeLa digest were purchased from Thermo Fisher (San Jose, Calif.). Affi-Gel® 10 was purchased from Biorad® (Hercules, Calif.). Amicon® filters were purchased from EMD Millipore® (Billerica, Mass.).

+ Open protocol
+ Expand
2

Escherichia coli Proteome Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Escherichia coli DH5α cell pellet was lysed by sonication using a Covaris M220 in a buffer containing 8 M urea and 100 mM TEAB. The protein amount was measured using a micro BCA protein assay kit (23235; ThermoFisher). The sample was reduced using a final concentration of 0.25 M DTT and alkylated with a final concentration of 8 mM IAA. The trypsin (V5280; Promega) was then added to 1:50 enzyme-to-protein ratio in 100 mM TEAB. The sample was acidified with a final concentration of 1% TFA before being loaded into the SPE micro-column. The peptides were eluted after two times of washing and were dried in a SpeedVac. Finally, E. coli proteins were reconstituted with 0.1% TFA and 1% ACN buffer. The HeLa digest (88329, ThermoFisher) was reconstituted with 0.1% TFA and 1% ACN. The E. coli digest and HeLa digest were mixed at the total mass ratio of 94:6 or 97:3.
+ Open protocol
+ Expand
3

Tryptic Peptide Analysis by UPLC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
For tryptic peptide analysis, a
nanoAcquity UPLC system equipped with a C18, 5 μm, 180 μm
× 20 mm trap column and a HSS-T3 C18 1.8 μm, 75 μm
× 250 mm analytical column (Waters Corporation, Manchester, UK)
was coupled to a Synapt G2 Si HDMS mass spectrometer with an electrospray
ionization source (Waters Corporation, Manchester, UK). Mobile phase
A contained 0.1% formic acid and 3% dimethyl sulfoxide in water and
mobile phase B 0.1% formic acid and 3% dimethyl sulfoxide in acetonitrile.
300 ng of protein was injected in trapping mode. The peptides were
separated at 40 °C with a gradient run from 3 to 40% (v/v) mobile
phase B at a flow rate of 0.3 μL/min over 120 min. Via the reference
channel, a lock mass solution composed of [Glu1]-fibrinopeptide B
(0.1 μM) and leu-enkephalin (1 μM) was introduced every
60 s. Peptide analysis was performed in positive ionization mode using
the ultra-definition MSE (UDMSE) approach.19 (link),20 (link) The reproducibility and stability of the method were controlled
with a commercially available HeLa digest (Thermo Scientific, Waltham,
MA).
+ Open protocol
+ Expand
4

Nanoflow UPLC-MS/MS Proteomic Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tryptic
peptides were analyzed with a nanoAcquity UPLC system coupled to a
Synapt G2-Si HDMS mass spectrometer with a nanoelectrospray ionization
source (Waters Corporation, Manchester, UK). The nanoAcquity UPLC
system consisted of a C18, 5 μm, 180 μm × 20 mm trap
column and an HSS-T3 C18 1.8 μm, 75 μm × 250 mm analytical
column (Waters Corporation, Manchester, UK) set to trapping mode.
Samples containing 300 ng of protein were injected in each run. Mobile
phases A and B consisted of 0.1% formic acid and 3% dimethyl sulfoxide
in water (v/v) and 0.1% formic acid and 3% dimethyl sulfoxide in acetonitrile
(v/v), respectively. Peptide separation was done using a gradient
from 3% to 40% (v/v) of mobile phase B at a constant flow rate of
0.3 μL/min over 120 min. Lock-mass correction was performed
by spraying a lock-mass solution containing [Glu1]-fibrinopeptide
B (0.1 μM) and leu-enkephalin (1 μM) through the reference
channel every 60 s. Data were acquired using a data-independent acquisition
workflow in positive ion mode with a UDMSE method.19 (link)−21 (link) The system’s performance and stability were monitored by
injecting a commercially available HeLa digest (Thermo Scientific,
Waltham, MA) after every seventh sample injection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!